Nifty 17196.7 (-1.18%)
Sensex 57696.46 (-1.31%)
Nifty Bank 36197.15 (-0.85%)
Nifty IT 35848.05 (-0.86%)
Nifty Financial Services 17779.5 (-1.13%)
Adani Ports 737.45 (-0.22%)
Asian Paints 3110.45 (-2.21%)
Axis Bank 673.00 (-0.46%)
B P C L 385.90 (1.86%)
Bajaj Auto 3287.85 (-1.22%)
Bajaj Finance 7069.25 (-1.55%)
Bajaj Finserv 17488.70 (-1.52%)
Bharti Airtel 718.35 (-1.94%)
Britannia Inds. 3552.00 (-0.74%)
Cipla 912.05 (-1.00%)
Coal India 159.75 (0.28%)
Divis Lab. 4757.05 (-0.42%)
Dr Reddys Labs 4596.50 (-1.42%)
Eicher Motors 2455.55 (0.16%)
Grasim Inds 1703.90 (-1.16%)
H D F C 2771.65 (-1.29%)
HCL Technologies 1171.40 (-1.12%)
HDFC Bank 1513.55 (-0.80%)
HDFC Life Insur. 690.95 (-2.03%)
Hero Motocorp 2462.45 (-0.41%)
Hind. Unilever 2343.65 (-1.66%)
Hindalco Inds. 424.65 (-1.72%)
I O C L 122.20 (1.28%)
ICICI Bank 716.30 (-0.84%)
IndusInd Bank 951.15 (0.59%)
Infosys 1735.55 (-0.73%)
ITC 221.65 (-1.69%)
JSW Steel 644.55 (-0.34%)
Kotak Mah. Bank 1914.20 (-2.55%)
Larsen & Toubro 1801.25 (0.67%)
M & M 836.95 (-1.48%)
Maruti Suzuki 7208.70 (-1.59%)
Nestle India 19321.35 (-0.93%)
NTPC 127.00 (-1.32%)
O N G C 145.90 (1.32%)
Power Grid Corpn 206.10 (-3.92%)
Reliance Industr 2408.25 (-3.00%)
SBI Life Insuran 1165.95 (-1.86%)
Shree Cement 25914.05 (-1.43%)
St Bk of India 473.15 (-0.81%)
Sun Pharma.Inds. 751.80 (-1.89%)
Tata Consumer 774.30 (0.14%)
Tata Motors 480.10 (0.21%)
Tata Steel 1118.00 (0.50%)
TCS 3640.45 (-0.07%)
Tech Mahindra 1593.30 (-2.23%)
Titan Company 2369.25 (-0.72%)
UltraTech Cem. 7332.45 (0.13%)
UPL 712.75 (2.08%)
Wipro 640.75 (-0.94%)
INFY

Vimta Labs Ltd.

₹375.65
Not a customer?

Open free demat account
& trade instantly

Investment Ratings

As per analysts rating in the last 6 months, the recommendation is to HOLD Vimta Labs

  • Master Rating:
  • Vimta Labs has an operating revenue of Rs. 229.47 Cr. on a trailing 12-month basis. An annual revenue growth of 15% is outstanding, Pre-tax margin of 14% is healthy, ROE of 11% is good. The company has a reasonable debt to equity of 7%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 15% and 42% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 8% from the pivot point (which is extended from the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 75 which is a FAIR score but needs to improve its earnings, a RS Rating of 80 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 148 indicates it belongs to a poor industry group of Medical-Research Eqp/Svc and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Vimta Labs Ltd Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Ratings

Eps And Sales Estimates

Vimta Labs Ltd Synopsis

NSE-Medical-Research Eqp/Svc

Vimta Labs Ltd. belongs to the Industry of Hospitals & Medical Services. Company’s Total Operating Revenue is Rs. 209.05 Cr. and Equity Capital is Rs. 4.42 Cr. for the Year ended 31/03/2021. Vimta Labs Ltd. is a Public Limited Listed company incorporated on 16/11/1990 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L24110TG1990PLC011977 and registration number is 011977.
  • Market Cap

    INR 829.16 Cr

  • Sales

    INR 253.38 Cr

  • Shares in Float

    1.39 Cr

  • No of Funds

    3 K

  • Yield

    0.53%

  • Book Value

    4.28

  • U/D Vol Ratio

    1.8

  • LTDebt/Equity

    7%

  • Alpha

    0.34

  • Beta

    0.78

Vimta Labs Ltd Ownership
Vimta Labs Ltd Management

Vimta Labs Ltd Financials

INDICATORMar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Total ShareHolders Funds Annual Cr 194.319172.959171.552152.053136.148
Fixed Assets Annual Cr 145.03132.905138.904140.39141.216
Total Non Current Assets Annual Cr 162.639148.897145.11148.692151.82
Total Current Assets Annual Cr 110.43595.63592.31783.56369.826
Total Assets Annual Cr 273.074244.532237.427232.255221.646
INDICATORMar 2021Mar 2020Mar 2019Mar 2018Mar 2017
Book Value Per Share Annual Rs 87.887278.226477.590268.77161.5774
ROE Annual % 10.94414.7510.87.77
ROCE Annual % 13.876.4620.4716.8611.48
Total Debt to Total Equity Annual -----
EBDIT Annual Margin % 25.5918.2827.9625.3218.36

Vimta Labs Ltd Technicals

EMA & SMA

CURRENT PRICE

375.65 (-0.24)

    • Bullish Moving Averages 16
    • Bearish Moving Averages 0

EMA

  • 20 Day

    359.87

  • 50 Day

    336.99

  • 100 Day

    310.96

  • 200 Day

    263.57

Vimta Labs Ltd Resistance and support

376.19 PIVOT

  • First Resistance

    382.37

  • Second Resistance

    388.19

  • Third Resistance

    394.37

  • First Support

    370.37

  • Second Support

    364.19

  • Third Support

    358.37

  • RSI

    59.74

  • MFI

    77.84

  • MACD

    12.75

  • MACD signal line

    13.33

Vimta Labs Ltd Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 72,490 4,041,318 55.75%
Week 211,950 9,406,341 44.38%
1 Month 192,317 8,502,339 44.21%
6 Month 250,102 9,814,013 39.24%

Vimta Labs Ltd Price change analysis

35.1

Over 1 month

Low High
340.6 405.25

83.15

Over 3 month

Low High
269.6 405.25

153.3

Over 6 months

Low High
221 405.25

227.95

Over Year

Low High
144 405.25

Similar Stocks

News

VIMTA LABS LTD.-$ - 524394 - Compliances-Reg. 39 (3) - Detai

Intimation regarding receipt of Information for loss of share certificate Read More

VIMTA LABS LTD.-$ - 524394 - Disclosure Of Related Party Tra

Related Party Transactions on consolidated basis for the half year ended September 30, 2021 Read More

VIMTA LABS LTD.-$ - 524394 - Compliances-Reg. 39 (3) - Detai

Intimation regarding receipt of Information for loss of share certificate. Read More

Hot Stocks | Here is why you should buy Vimta Labs and sell

Going ahead, since the market is a bit oversold, we may see some relief move in between; but traders should not get carried away by such reb Read More

Vimta Labs Ltd - 524394 - Announcement under Regulation 30 (

Transcript of the Q2-2022 earnings/investor call held on 25th October 2021. Read More

Blogs

FAQs